Niacin Intake and Incident Adult-Onset Atopic Dermatitis in Women.
Aaron M Drucker,Wen-Qing Li,Min Kyung Park,Tricia Li,Abrar A Qureshi,Eunyoung Cho
DOI: https://doi.org/10.1016/j.jaci.2016.12.956
2017-01-01
Abstract:Adult-onset atopic dermatitis (AD) is a recognized entity,1Hanifin J.M. Reed M.L. Eczema P. Impact Working GroupA population-based survey of eczema prevalence in the United States.Dermatitis. 2007; 18: 82-91Crossref PubMed Scopus (267) Google Scholar but little is known about risk factors for its development. Results from a randomized controlled trial of coated oral nicotinamide tablets for the prevention of skin cancer found that nicotinamide modestly decreased transepidermal water loss (TEWL), a measure of epidermal barrier integrity, among participants.2Chen A.C. Martin A.J. Dalziell R.A. Halliday G.M. Damian D.L. Oral nicotinamide reduces transepidermal water loss: a randomised controlled trial.Br J Dermatol. 2016; 175: 1363-1365Crossref PubMed Scopus (13) Google Scholar Nicotinamide is a derivative of niacin (vitamin B3, nicotinic acid), a nutrient found in many foods and supplements, including B vitamin complex and multivitamins. Given that increases in TEWL are associated with AD,3Holm E.A. Wulf H.C. Thomassen L. Jemec G.B. Assessment of atopic eczema: clinical scoring and noninvasive measurements.Br J Dermatol. 2007; 157: 674-680Crossref PubMed Scopus (36) Google Scholar we hypothesized that increased niacin intake would be protective from the development of AD in adulthood. We aimed to investigate this association in the Nurses' Health Study 2 (NHS2), a large prospective cohort study of US female nurses. NHS2 was established in 1989 with 116,430 participants between the ages of 25 and 42 years. Follow-up questionnaires are sent biennially to participants, updating information on diseases, anthropometric factors, and other risk factors. Height and race/ethnicity were assessed at cohort baseline. Smoking status, physical activity, postmenopausal hormone use, and history of asthma, hypertension, hypercholesterolemia, type 2 diabetes, and cardiovascular disease (myocardial infarction and stroke) are all assessed and updated during cohort follow-up. AD was assessed by self-report in 2013 when participants were asked about a history of clinician-diagnosed “eczema (atopic dermatitis),” in addition to the year they were diagnosed in intervals (before 1995, 1995-2002, 2003-2008, 2009-2010, 2011+). In this analysis, we included only incidence cases with reported diagnosis after 1995. Cases of AD diagnosed before 1995, when participants were between the ages of 31 and 48 years, were excluded. A validated food frequency questionnaire was used to collect dietary information in 1991 and every 4 years thereafter.4Feskanich D. Rimm E.B. Giovannucci E.L. Colditz G.A. Stampfer M.J. Litin L.B. et al.Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire.J Am Diet Assoc. 1993; 93: 790-796Abstract Full Text Full Text PDF PubMed Scopus (886) Google Scholar, 5Rimm E.B. Giovannucci E.L. Stampfer M.J. Colditz G.A. Litin L.B. Willett W.C. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.Am J Epidemiol. 1992; 135 (discussion 1127-36): 1114-1126Crossref PubMed Scopus (1766) Google Scholar Participants responded to questions regarding how often on average they consumed specific types of food and drink, including alcohol, during the previous year. Total niacin intake was calculated using intake from both dietary sources and supplements using cumulative average intake up to the start of each follow-up interval to represent long-term dietary intake and to reduce measurement errors. We followed participants for incident AD starting from 1995. Participants who reported AD diagnosed before 1995, who did not return the 2013 questionnaire, and those missing niacin intake information were excluded, leaving 67,643 participants in the analysis. Person-time of follow-up was calculated from the return month of the 1995 questionnaire to the date of the first report of AD or end of follow-up (June 2013), whichever came first. Cox proportional hazard models were used to compute the hazard ratios and 95% CI of AD with total, dietary, and supplemental niacin intakes in quintiles. A separate analysis was conducted with B vitamin complex and multivitamin intake as the exposures. Covariates used in multivariate analyses are listed in the table legends. The most recent information for time-varying variables before each follow-up interval was used to take into account potential changes over the follow-up. Trend tests were performed by assigning median values for niacin intake categories and treating the new variable as a continuous term in the models. We performed stratified analyses by history of asthma and by history of hypertension, hypercholesterolemia, type 2 diabetes, and cardiovascular disease. Because niacin can be generated from dietary tryptophan, we performed a sensitivity analysis incorporating the contribution of tryptophan intake into our dietary and total niacin intake variables, using a 60:1 tryptophan to niacin conversion factor.6Horwitt M.K. Harper A.E. Henderson L.M. Niacin-tryptophan relationships for evaluating niacin equivalents.Am J Clin Nutr. 1981; 34: 423-427Crossref PubMed Scopus (60) Google Scholar We used SAS software version 9.2 (SAS Institute Inc, Cary, NC) for all statistical analyses. All statistical tests were 2-tailed, and the significance level was set at P < .05. Characteristics of the cohort according to quintiles of total niacin intake are presented in Table I. Participant characteristics were similar across quintiles of niacin intake, but physical activity appeared to increase with niacin intake.Table ICharacteristics of participants by total baseline (1995) niacin intake in quintilesCharacteristicQuintiles of total niacin intakeQ1Q2Q3Q4Q5Number of participants13,40413,79013,36013,56113,528Age (y)∗Value is not age-adjusted.40.3 ± 4.640.5 ± 4.540.3 ± 4.639.9 ± 4.840.8 ± 4.7Total niacin intake (mg/d)†Value is energy-adjusted.19.3 (2.4)24.2 (1.1)28.9 (1.9)38.5 (3.4)73.6 (36.5)Dietary niacin intake (mg/d)†Value is energy-adjusted.19.6 (2.5)23.9 (2.0)26.3 (4.1)24.9 (5.4)26.4 (7.2)Supplemental niacin intake (mg/d)0.2 (0.8)0.4 (1.3)2.6 (4.4)13.7 (6.6)44.0 (33.7)Body mass index (kg/m2)25.5 (5.9)25.8 (5.8)26.0 (5.8)25.4 (5.5)25.3 (5.6)Physical activity level (metabolic-equivalents h/wk)18.6 (25.3)18.8 (23.9)20.2 (24.3)22.3 (28.3)23.8 (30.6)Alcohol consumption (g/d)3.4 (7.1)3.6 (6.4)3.7 (6.7)3.5 (6.3)3.4 (6.6)Current smoking, %11.110.59.78.18.7Past smoking, %21.523.425.423.925.5Postmenopausal, %6.66.76.77.28.0Hormone use among postmenopausal, %82.885.185.088.687.2Total energy intake (kcal/d)1660 (528)1824 (535)1937 (557)1941 (543)1701 (537)White race, %95.796.596.696.696.0History of cardiovascular disease, %0.10.10.10.10.1History of type 2 diabetes, %0.30.50.60.50.6History of hypertension, %8.58.89.38.99.7History of hypercholesterolemia, %19.919.921.120.622.7History of asthma, %8.79.29.08.910.8Values are mean ± SD or percentages and are standardized to the age distribution of the study population.∗ Value is not age-adjusted.† Value is energy-adjusted. Open table in a new tab Values are mean ± SD or percentages and are standardized to the age distribution of the study population. We did not find an inverse association between niacin intake and risk of AD. In contrast, increased niacin intake was associated with increased risk of AD (Ptrend = .0009) in the multivariate-adjusted model (Table II). This positive association was significant for supplemental niacin intake (Ptrend = .01) but not for dietary niacin intake (Ptrend = .83). Significant positive associations were also seen with B complex and multivitamin supplement intake (see Table E1 in this article's Online Repository at www.jacionline.org). In the stratified analysis by history of asthma, increased risk for AD was seen only with total and supplementary niacin intake among participants without asthma (see Table E2 in this article's Online Repository at www.jacionline.org). In the stratified analysis by history of cardiovascular risk factors and disease and in the sensitivity analysis incorporating tryptophan intake, there was no material difference in the results (data not shown).Table IIRisk of AD associated with total, dietary, and supplemental niacin intake among participants in the NHS2 (1995-2013)Categories of niacin intakeMedian niacin intake (mg/d)Person-yearsAD casesAge-adjusted HR (95% CI)MV-adjusted HR (95% CI)∗Adjusted for body mass index (in 10 categories), smoking status (never, past, current [1-14, 15-25, 25+ cigarettes per day]), physical activity (quintiles), alcohol intake (0, 0.1-4.9, 5-9.9, 10+ g/d), race (white, other), history of hypertension, hypercholesterolemia, type 2 diabetes, cardiovascular disease (myocardial infarction or stroke), and asthma, postmenopausal hormone use, and total calorie intake (quartiles).Total niacin intake First quintile19.9237,3673551.00 (reference)1.00 (reference) Second quintile24.2239,7933791.05 (0.91-1.21)1.04 (0.90-1.20) Third quintile28.7238,6753821.06 (0.91-1.22)1.05 (0.90-1.21) Fourth quintile38.4239,4384271.17 (0.91-1.22)1.16 (1.01-1.34) Fifth quintile59.9239,2454581.26 (1.09-1.44)1.23 (1.07-1.42)P for trend.0003.0009Dietary niacin intake First quintile18.5241,1824071.00 (reference)1.00 (reference) Second quintile21.7238,2423900.97 (0.84-1.11)0.95 (0.83-1.09)†Additionally adjusted for supplementary niacin intake (in categories). Third quintile23.8236,7773880.97 (0.84-1.11)0.95 (0.83-1.09)†Additionally adjusted for supplementary niacin intake (in categories). Fourth quintile26.0238,5734131.02 (0.89-1.17)1.00 (0.87-1.14)†Additionally adjusted for supplementary niacin intake (in categories). Fifth quintile30.0239,7444030.99 (0.86-1.13)0.96 (0.84-1.11)†Additionally adjusted for supplementary niacin intake (in categories).P for trend.90.82Supplemental niacin intake None0343,4565061.00 (reference)1.00 (reference) 0.1-2.0 mg/d1.657,287820.90 (0.71-1.15)0.92 (0.72-1.17)‡Additionally adjusted for dietary niacin intake (in quintiles). 2.1-10 mg/d2.8247,2044110.99 (0.87-1.14)1.00 (0.87-1.15)‡Additionally adjusted for dietary niacin intake (in quintiles). 10.1-18 mg/d11.4204,1653591.01 (0.87-1.16)1.02 (0.88-1.17)‡Additionally adjusted for dietary niacin intake (in quintiles). >18 mg/d20.0342,4066431.16 (1.03-1.31)1.15 (1.02-1.30)‡Additionally adjusted for dietary niacin intake (in quintiles).P for trend.007.01HR, Hazard ratio; MV, multivariate.∗ Adjusted for body mass index (in 10 categories), smoking status (never, past, current [1-14, 15-25, 25+ cigarettes per day]), physical activity (quintiles), alcohol intake (0, 0.1-4.9, 5-9.9, 10+ g/d), race (white, other), history of hypertension, hypercholesterolemia, type 2 diabetes, cardiovascular disease (myocardial infarction or stroke), and asthma, postmenopausal hormone use, and total calorie intake (quartiles).† Additionally adjusted for supplementary niacin intake (in categories).‡ Additionally adjusted for dietary niacin intake (in quintiles). Open table in a new tab HR, Hazard ratio; MV, multivariate. Contrary to our hypothesis, total niacin intake was not protective for adult-onset AD in this study, and it appeared to increase the risk in a dose-dependent fashion as indicated by the significant trend tests. In previous studies, intake of nicotinamide, a derivative of niacin, decreased TEWL,2Chen A.C. Martin A.J. Dalziell R.A. Halliday G.M. Damian D.L. Oral nicotinamide reduces transepidermal water loss: a randomised controlled trial.Br J Dermatol. 2016; 175: 1363-1365Crossref PubMed Scopus (13) Google Scholar and maternal serum nicotinamide levels in late pregnancy were protective from the development of AD at 12 months in their offspring.7El-Heis S. Crozier S.R. Robinson S.M. Harvey N.C. Cooper C. Inskip H.M. et al.Higher maternal serum concentrations of nicotinamide and related metabolites in late pregnancy are associated with a lower risk of offspring atopic eczema at age 12 months.Clin Exp Allergy. 2016; 46: 1337-1343Crossref PubMed Scopus (13) Google Scholar The positive association of niacin intake with AD risk in our study appeared to be driven by supplemental niacin intake in the form of B complex vitamins and multivitamins, rather than dietary niacin intake. Although our findings are interesting, it is not clear why this relationship exists and what specific components of these supplements are causing the association; we cannot directly attribute this risk to niacin alone. Our stratified analysis by cardiovascular risk factors and disease suggest that the associations seen were not due to confounding by increased supplement intake in participants with those comorbidities; nevertheless, despite controlling for a number of important covariates, we cannot rule out residual confounding by unmeasured factors. For example, NHS2 does not collect data on carcinoid syndrome, a rare condition that can lead to skin eruptions and derangements in niacin metabolism. Our study is strengthened by the well-established cohort with high-quality data on participant characteristics and dietary factors. Although NHS2 is a prospective study, elements of our analysis are retrospective, including participants' recall of their date of AD diagnosis. Self-reported history of AD in adults has good specificity and positive predictive value but sensitivity is low.8Silverberg J.I. Patel N. Immaneni S. Rusniak B. Silverberg N.B. Debashis R. et al.Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study.Br J Dermatol. 2015; 173: 1400-1404Crossref PubMed Scopus (85) Google Scholar Some cases of reported adult-onset AD may represent cases of unremembered childhood AD followed by a prolonged remission and eventual relapse in adulthood. Other cases may represent other forms of dermatitis, including the possibility, though rare, that participants experience a systemic allergic contact dermatitis to components of supplement pills or capsules. We plan to conduct studies to better characterize the AD phenotype among NHS2 participants in the future. The study's inclusion of women only, predominantly white population, and high median age (40 years) limit its generalizability. Caution must be taken when extrapolating our findings to other populations, including men, other races/ethnicities, and other age groups. It is also important to note that although nicotinamide is a derivative of niacin, our study uses measures of niacin intake specifically, rather than nicotinamide, which was supplemented in the previously referenced randomized controlled trial.2Chen A.C. Martin A.J. Dalziell R.A. Halliday G.M. Damian D.L. Oral nicotinamide reduces transepidermal water loss: a randomised controlled trial.Br J Dermatol. 2016; 175: 1363-1365Crossref PubMed Scopus (13) Google Scholar In conclusion, niacin intake was not protective for the development of AD in adulthood in this study of US women. Our findings of increased risk of AD with supplementary B complex and multivitamin intake should be replicated in other populations and warrant further study before any specific clinical recommendations can be made. In addition, studies examining the clinical course of established AD in relation to B vitamin intake would be beneficial. The results of this study do not support a role for supplementary niacin intake as a means to prevent AD in adults. Table E1Risk of AD associated with vitamin B complex and multivitamin use among participants in the NHS2 (1995-2013)Supplement usePerson-yearsAD casesAge-adjusted HR (95% CI)MV-adjusted HR (95% CI)∗Adjusted for body mass index (in 10 categories), smoking status (never, past, current [1-14, 15-25, 25+ cigarettes per day], physical activity (quintiles), alcohol intake (0, 0.1-4.9, 5-9.9, 10+ g/d), race (white, other), history of hypertension, hypercholesterolemia, type 2 diabetes, cardiovascular disease (myocardial infarction or stroke), and asthma, postmenopausal hormone use, and total calorie intake (quartiles).Use of B vitamin complex No1,011,5841,6611.00 (reference)1.00 (reference) Yes90,6811621.22 (1.04-1.44)1.20 (1.02-1.41)Use of multivitamins No482,3447341.00 (reference)1.00 (reference) Yes638,9261,1331.11 (1.01-1.22)1.11 (1.01-1.22)Use of B vitamin complex and multivitamins No B vitamin complex or multivitamin intake451,2026851.00 (reference)1.00 (reference) B vitamin complex only23,362331.01 (0.71-1.43)1.02 (0.72-1.44) Multivitamin only560,3829761.08 (0.98-1.19)1.09 (0.99-1.20) Both B vitamin complex and multivitamin intake67,3191291.38 (1.14-1.66)1.35 (1.12-1.63)HR, Hazard ratio; MV, multivariate.∗ Adjusted for body mass index (in 10 categories), smoking status (never, past, current [1-14, 15-25, 25+ cigarettes per day], physical activity (quintiles), alcohol intake (0, 0.1-4.9, 5-9.9, 10+ g/d), race (white, other), history of hypertension, hypercholesterolemia, type 2 diabetes, cardiovascular disease (myocardial infarction or stroke), and asthma, postmenopausal hormone use, and total calorie intake (quartiles). Open table in a new tab Table E2Risk of AD associated with total, dietary and supplemental niacin intake stratified by history of asthma among participants in the NHS2 (1995-2013)Niacin intakePerson-yearsAD casesAge-adjusted HR (95% CI)MV-adjusted HR (95% CI)∗Adjusted for body mass index (in 10 categories), smoking status (never, past, current [1-14, 15-25, 25+ cigarettes per day], physical activity (quintiles), alcohol intake (0, 0.1-4.9, 5-9.9, 10+ g/day), race (white, other), history of hypertension, hypercholesterolemia, type 2 diabetes, and cardiovascular disease (myocardial infarction or stroke), postmenopausal hormone use, and total calorie intake (quartiles).No asthmaTotal niacin intake First quintile207,6502961.00 (reference)1.00 (reference) Second quintile209,4992970.99 (0.84-1.16)0.99 (0.84-1.16) Third quintile207,1312920.98 (0.83-1.15)0.98 (0.83-1.15) Fourth quintile206,3863281.09 (0.93-1.27)1.10 (0.94-1.29) Fifth quintile200,9343561.22 (1.05-1.43)1.22 (1.04-1.43)P for trend.0013.0012AsthmaTotal niacin intake First quintile29,717591.00 (reference)1.00 (reference) Second quintile30,293821.33 (0.95-1.86)1.31 (0.93-1.83) Third quintile31,544901.40 (1.01-1.94)1.37 (0.98-1.90) Fourth quintile33,051991.47 (1.07-2.03)1.45 (1.05-2.01) Fifth quintile38,3111021.31 (0.95-1.81)1.30 (0.94-1.80)P for trend.36.37HR, Hazard ratio; MV, multivariate.∗ Adjusted for body mass index (in 10 categories), smoking status (never, past, current [1-14, 15-25, 25+ cigarettes per day], physical activity (quintiles), alcohol intake (0, 0.1-4.9, 5-9.9, 10+ g/day), race (white, other), history of hypertension, hypercholesterolemia, type 2 diabetes, and cardiovascular disease (myocardial infarction or stroke), postmenopausal hormone use, and total calorie intake (quartiles). Open table in a new tab HR, Hazard ratio; MV, multivariate. HR, Hazard ratio; MV, multivariate.